Clinical Trials Logo
  1. Home
  2. Hypothalamic Amenorrhea
  3. NCT02984696

Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea

Hypothalamic Amenorrhea Clinical Trial

Official title:
Effects of 6 Months of HRT on Total Antioxidant Capacity in Patients Affected by Hypotalamic Amenorrhea

Clinical Trial Summary

The aim of our study is to investigate the effects of 6 months oh HRT on total anti-oxidant capacity, clinical, endocrine and metabolic features in women affected by hypotalamic amenorrhea. The study group included 20 patients treated with 1 mg of transdermal estradiol daily and 10mg of oral Medroxyprogesterone acetate from 16th to 24th day of therapy for six months. Menstrual pattern, anthropometric parameters, hormonal assays, DXA and bone metabolism parameters are evaluated before and after therapy.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02984696
Study type Interventional
Source Catholic University of the Sacred Heart
Contact
Status Recruiting
Phase N/A
Start date March 2015
Completion date December 2017
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT01601171 - Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
Completed NCT00556036 - Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea
Terminated NCT01165619 - Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders N/A
Recruiting NCT03841981 - Body Fat as Determinant of Female Gonadal Dysfunction
Recruiting NCT05629377 - Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health (ARCH)
Completed NCT03018366 - Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women Phase 2
Recruiting NCT05633966 - Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders Phase 1
Terminated NCT00889512 - The Luveris In Vitro Fertilization Trial Phase 4